ES2103271T3 - Dispositivo para administrar un agente activo a la piel o a mucosas. - Google Patents

Dispositivo para administrar un agente activo a la piel o a mucosas.

Info

Publication number
ES2103271T3
ES2103271T3 ES90905296T ES90905296T ES2103271T3 ES 2103271 T3 ES2103271 T3 ES 2103271T3 ES 90905296 T ES90905296 T ES 90905296T ES 90905296 T ES90905296 T ES 90905296T ES 2103271 T3 ES2103271 T3 ES 2103271T3
Authority
ES
Spain
Prior art keywords
membrane
layer
backing
peelable
reservoir
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90905296T
Other languages
English (en)
Inventor
Yunik Chang
Dinesh C Patel
Charles D Ebert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Actavis Laboratories UT Inc
Original Assignee
Theratech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23272639&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2103271(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Theratech Inc filed Critical Theratech Inc
Application granted granted Critical
Publication of ES2103271T3 publication Critical patent/ES2103271T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/02—Adhesive bandages or dressings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Devices For Medical Bathing And Washing (AREA)

Abstract

DISPOSITIVO DE ABASTECIMIENTO DE DROGA TRANSDERMAL (11) QUE COMPRENDE UN RECIPIENTE CONTENEDOR DE FORMULACION DE DROGA (13) DEFINIDO MEDIANTE UNA CAPA DE APOYO (112) Y UNA CAPA DE MEMBRANA PERMEABLE A LA DROGA (16), UN REVESTIDOR INTERNO DESPEGABLE (20) QUE SE EXTIENDE DEBAJO DEL RECIPIENTE Y UNA PORCION DE EL APOYO LA MEMBRANA HACIA AFUERA DE LA PERIFERIA DEL RECIPIENTE, UNA CAPA ADHESIVA (15) QUE SE EXTIENDE DEBAJO DEL REVESTIDOR INTERNO Y DE LAS PORCIONES QUE SE EXTIENDEN HACIA AFUERA DE LAS CAPAS DE MEMBRANA/APOYO, Y UNA CAPA DE REVESTIDOR DE DESPRENDIMIENTO DESPEGABLE (17) QUE SE EXTIENDE DEBAJO DE LA CAPA ADHESIVA CON UN PRIMER SELLO TERMICO PERMANENTE (18) ENTRE EL APOYO Y LA MEMBRANA ALREDEDOR DEL PERIMETRO DEL RECIPIENTE Y OTRO SELLO TERMICO (IMPERMEABLE) DESPEGABLE (19) ENTRE LA MEMBRANA Y EL REVESTIDOR INTERNO QUE SE EXTIENDE DEBAJO DEL PRIMER SELLO TERMICO PERMANENTE, PROPORCIONANDO LOS SELLOS TERMICOS Y LA CAPA DE BARRERA DESPEGABLE BARRERAS QUE AISLAN LA FORMULACION DE LA DROGA DEL ADHESIVO.
ES90905296T 1989-03-21 1990-03-21 Dispositivo para administrar un agente activo a la piel o a mucosas. Expired - Lifetime ES2103271T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/326,536 US4983395A (en) 1987-11-12 1989-03-21 Device for administering an active agent to the skin or mucosa

Publications (1)

Publication Number Publication Date
ES2103271T3 true ES2103271T3 (es) 1997-09-16

Family

ID=23272639

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90905296T Expired - Lifetime ES2103271T3 (es) 1989-03-21 1990-03-21 Dispositivo para administrar un agente activo a la piel o a mucosas.

Country Status (12)

Country Link
US (1) US4983395A (es)
EP (1) EP0464106B1 (es)
JP (1) JPH0818976B2 (es)
KR (1) KR0149492B1 (es)
AT (1) ATE154751T1 (es)
AU (1) AU631417B2 (es)
CA (1) CA2053272C (es)
DE (1) DE69030974T2 (es)
DK (1) DK0464106T3 (es)
ES (1) ES2103271T3 (es)
HK (1) HK1003322A1 (es)
WO (1) WO1990011065A1 (es)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5240711A (en) * 1989-11-29 1993-08-31 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg Transdermal therapeutic system comprising as active component buprenorphine
US5130139A (en) * 1990-07-06 1992-07-14 Alza Corporation Reduction or prevention of skin irritation by drugs
US5160741A (en) * 1990-07-06 1992-11-03 Alza Corporation Reduction or prevention of skin irritation by drugs
US5484604A (en) * 1990-07-21 1996-01-16 Chatfield Pharmaceuticals Limited Cross-linked alginate transdermal medicine delivery devices
US5064422A (en) * 1990-10-18 1991-11-12 Bertek, Inc. Twin patch applicator
US5202125A (en) * 1990-12-10 1993-04-13 Theratech, Inc. Method and systems for administering nitroglycerin transdermally at enhanced transdermal fluxes
AU646453B2 (en) * 1991-04-26 1994-02-24 Astra Aktiebolag Topical dressings
US5883115A (en) * 1992-11-09 1999-03-16 Pharmetrix Division Technical Chemicals & Products, Inc. Transdermal delivery of the eutomer of a chiral drug
WO1994022432A1 (en) * 1993-04-07 1994-10-13 Rexham Industries Corp. Method of coating microporous membranes and resulting products
US5886026A (en) * 1993-07-19 1999-03-23 Angiotech Pharmaceuticals Inc. Anti-angiogenic compositions and methods of use
DE69435002T2 (de) 1993-07-19 2008-03-20 Angiotech Pharmaceuticals, Inc., Vancouver Anti-angiogene Mittel enthaltend Taxol und einen nicht biodegradierbaren Träger und deren Verwendung
DE4341444C2 (de) * 1993-12-04 1996-03-14 Lohmann Therapie Syst Lts Wirkstoffhaltiges Pflaster und Verfahren zu seiner Herstellung
US5656279A (en) * 1994-02-23 1997-08-12 Bio Med Sciences, Inc. Semi-interpenetrating polymer network scar treatment sheeting, process of manufacture and useful articles thereof
CN1170360A (zh) * 1994-12-21 1998-01-14 瑟垃技术有限公司 具有粘性贴面和剥离密封圆片的经皮输送系统
US20020048596A1 (en) * 1994-12-30 2002-04-25 Gregor Cevc Preparation for the transport of an active substance across barriers
US5780050A (en) * 1995-07-20 1998-07-14 Theratech, Inc. Drug delivery compositions for improved stability of steroids
US5759560A (en) * 1995-07-27 1998-06-02 Bio Med Sciences, Inc. Silicone thermoplastic sheeting for scar treatment and useful article thereof; process of manufacture and use
US5733571A (en) * 1995-12-08 1998-03-31 Euro-Celtique, S.A. Transdermal patch for comparative evaluations
US5730721A (en) * 1996-01-25 1998-03-24 Vesture Corporation Medical applicator and method
US5952000A (en) * 1996-10-30 1999-09-14 Theratech, Inc. Fatty acid esters of lactic acid salts as permeation enhancers
US5968547A (en) * 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
ES2173679T3 (es) 1999-01-27 2002-10-16 Idea Ag Inmunizacion/transporte transnasal con vehiculos altamente adaptables.
SI1031346T1 (en) 1999-01-27 2002-08-31 Idea Ag Noninvasive vaccination through the skin
WO2000054755A1 (en) * 1999-03-17 2000-09-21 Barbara Sheila Goldberg An adhesive dispensing arrangement
US7063859B1 (en) 1999-04-28 2006-06-20 Noven Pharmaceuticals, Inc. Barrier film lined backing layer composition and method for topical administration of active agents
US6277401B1 (en) 1999-05-07 2001-08-21 U.S. Dermatologics, Inc. Drug delivery device
CN1220491C (zh) * 1999-06-11 2005-09-28 沃特森药物公司 非口服雄激素类固醇用于制备改善性激素结合球蛋白水平升高的药物
MXPA02000053A (es) * 1999-07-05 2003-07-21 Idea Ag Un metodo para mejorar el tratamiento a traves de barreras adaptables semipermeables.
GB9917290D0 (en) * 1999-07-22 1999-09-22 Glaxo Wellcome Spa Pharmaceutical composition
CN1240384C (zh) * 1999-11-04 2006-02-08 美国爱科赛尔制药有限公司 石杉碱经皮给药制剂
US20050042271A1 (en) * 1999-11-19 2005-02-24 Xel Herbaceuticals, Inc . Transdermal delivery system for alkaloids of aconitum species
US6896898B1 (en) 1999-11-19 2005-05-24 Xel Herbaceuticals, Inc. Transdermal delivery system for alkaloids of aconitum species
USRE44145E1 (en) 2000-07-07 2013-04-09 A.V. Topchiev Institute Of Petrochemical Synthesis Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
FR2822711B1 (fr) 2001-03-28 2003-06-13 Oreal Dispositif de traitement comportant une enveloppe definissant une cavite dans laquelle peut-etre engagee une partie du corps
KR100438254B1 (ko) * 2001-03-29 2004-07-02 아이큐어 주식회사 비타민 ｄ 유사체를 포함하는 매트릭스형 경피흡수제제
US20050113510A1 (en) 2001-05-01 2005-05-26 Feldstein Mikhail M. Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components
US8206738B2 (en) 2001-05-01 2012-06-26 Corium International, Inc. Hydrogel compositions with an erodible backing member
EP1390084B1 (en) * 2001-05-01 2011-03-23 A.V. Topchiev Institute of Petrochemical Synthesis Two-phase, water-absorbent bioadhesive composition
US8541021B2 (en) * 2001-05-01 2013-09-24 A.V. Topchiev Institute Of Petrochemical Synthesis Hydrogel compositions demonstrating phase separation on contact with aqueous media
CA2445086C (en) * 2001-05-01 2008-04-08 A.V. Topchiev Institute Of Petrochemical Synthesis Hydrogel compositions
US20050215727A1 (en) 2001-05-01 2005-09-29 Corium Water-absorbent adhesive compositions and associated methods of manufacture and use
US8840918B2 (en) * 2001-05-01 2014-09-23 A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences Hydrogel compositions for tooth whitening
US20050163829A1 (en) * 2001-12-07 2005-07-28 Norbert Hoenzelaer Device and patch for controlled release of vanillin
US7921999B1 (en) 2001-12-20 2011-04-12 Watson Laboratories, Inc. Peelable pouch for transdermal patch and method for packaging
US7473432B2 (en) * 2002-10-11 2009-01-06 Idea Ag NSAID formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery
CA2729967C (en) * 2002-12-13 2018-01-16 Scholl's Wellness Company Llc Use of a transdermal or transmucosal ingredient delivery device
US8524272B2 (en) 2003-08-15 2013-09-03 Mylan Technologies, Inc. Transdermal patch incorporating active agent migration barrier layer
US8784874B2 (en) * 2003-09-10 2014-07-22 Noven Pharmaceuticals, Inc. Multi-layer transdermal drug delivery device
EP1682061B1 (en) * 2003-10-28 2017-03-15 Noven Pharmaceuticals, Inc. Transdermal drug delivery device
US7105263B2 (en) * 2003-12-30 2006-09-12 Samsung Electronics Company Dry toner comprising encapsulated pigment, methods and uses
KR20070007299A (ko) 2004-01-30 2007-01-15 코리움 인터네셔널, 인크. 활성제의 전달을 위한 급속 용해 필름
US20060008432A1 (en) * 2004-07-07 2006-01-12 Sebastiano Scarampi Gilsonite derived pharmaceutical delivery compositions and methods: nail applications
AU2005271259B2 (en) * 2004-08-05 2012-01-19 A.V. Topchiev Institute Of Petrochemical Synthesis Adhesive composition
WO2006041907A2 (en) 2004-10-08 2006-04-20 Noven Pharmaceuticals, Inc. Transdermal delivery of estradiol
CA2584475A1 (en) * 2004-11-12 2006-05-18 Idea Ag Extended surface aggregates in the treatment of skin conditions
DE602006016441D1 (de) * 2005-05-13 2010-10-07 Alza Corp Mehrlagiges arzneimittelausbringsystem mit sperre gegen reservoirmaterialfluss
US8008453B2 (en) 2005-08-12 2011-08-30 Amgen Inc. Modified Fc molecules
US10137135B2 (en) 2005-08-15 2018-11-27 Allergan Sales, Llc Formulations and methods for providing progestin-only contraception while minimizing adverse side effects associated therewith
US7955677B2 (en) * 2005-12-07 2011-06-07 Mylan Technologies, Inc. Two-sided non-stick release film
PE20081140A1 (es) * 2006-10-25 2008-09-22 Amgen Inc Agentes terapeuticos a base de peptidos derivados de toxinas
JP5591691B2 (ja) 2007-05-22 2014-09-17 アムジエン・インコーポレーテツド 生物活性を有する融合タンパク質を作製するための組成物及び方法
US8246978B2 (en) 2007-07-10 2012-08-21 Agile Therapeutics, Inc. Dermal delivery device with reduced loss of its volatile components
US8231906B2 (en) 2008-07-10 2012-07-31 Noven Pharmaceuticals, Inc. Transdermal estrogen device and delivery
CN102223791A (zh) 2008-09-27 2011-10-19 塔阿克斯有限公司 用于神经病变治疗的局部用制剂
CA2751884C (en) * 2009-01-14 2018-09-25 Corium International, Inc. Transdermal administration of tamsulosin
US8920392B2 (en) 2009-05-05 2014-12-30 Watson Laboratories, Inc. Method for treating overactive bladders and a device for storage and administration of topical oxybutynin compositions
SG10201601789TA (en) 2011-03-16 2016-04-28 Amgen Inc Potent And Selective Inhibitors Of Nav1.3 And Nav1.7
EP2765983A1 (de) 2011-10-11 2014-08-20 Hans Kosak Zusammensetzung zur einbringung von nukleinsäuren in zellen
US9656051B2 (en) 2011-12-01 2017-05-23 Avery Dennison Retail Information Services, Llc Devices with selectively permeable barriers
KR20150119468A (ko) 2013-02-28 2015-10-23 더미라, 인코포레이티드 글리코피롤레이트 염
US9006462B2 (en) 2013-02-28 2015-04-14 Dermira, Inc. Glycopyrrolate salts
US8558008B2 (en) 2013-02-28 2013-10-15 Dermira, Inc. Crystalline glycopyrrolate tosylate
US10344060B2 (en) 2013-03-12 2019-07-09 Amgen Inc. Potent and selective inhibitors of Nav1.7
US20150157509A1 (en) * 2013-12-11 2015-06-11 Oscar Polk Atkinson Occlusive skin covering
CN110475548A (zh) * 2016-12-29 2019-11-19 纯比率控股股份有限公司 模块化透皮递送系统以及相关制备和使用方法
US11318190B2 (en) 2017-05-05 2022-05-03 United States Government As Represented By The Department Of Veterans Affairs Methods and compositions for treating liver disease
KR20250067227A (ko) 2023-11-07 2025-05-15 김숙구 열감성 항균 및 항염성 조성물, 열감성 여성청결제 및 이의 제조방법
KR20250067228A (ko) 2023-11-07 2025-05-15 김숙구 냉감성 항균 및 항염성 조성물, 냉감성 여성청결제 및 이의 제조방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5855411A (ja) * 1981-09-28 1983-04-01 Nitto Electric Ind Co Ltd 基剤組成物および外用医薬組成物
US4696821A (en) * 1983-10-11 1987-09-29 Warner-Lambert Company Transdermal delivery system for administration of nitroglycerin
US4573996A (en) * 1984-01-03 1986-03-04 Jonergin, Inc. Device for the administration of an active agent to the skin or mucosa
US4637930A (en) * 1984-02-08 1987-01-20 Yamanouchi Pharmaceutical Co, Ltd. Transdermal formulation of nicardipine hydrochloride
ES8608895A1 (es) * 1984-08-17 1986-07-16 Allpack Ind Lohnverpackung Parche adhesivo farmaceutico y procedimiento para su fabri- cacion
US4710191A (en) * 1985-12-16 1987-12-01 Jonergin, Inc. Therapeutic device for the administration of medicaments
JPH0744940B2 (ja) * 1986-12-24 1995-05-17 ライオン株式会社 口腔貼付用基材
US4764379A (en) * 1987-08-24 1988-08-16 Alza Corporation Transdermal drug delivery device with dual permeation enhancers
US4849224A (en) * 1987-11-12 1989-07-18 Theratech Inc. Device for administering an active agent to the skin or mucosa

Also Published As

Publication number Publication date
JPH0818976B2 (ja) 1996-02-28
EP0464106A4 (en) 1993-09-22
CA2053272A1 (en) 1990-09-22
KR920700019A (ko) 1992-02-19
ATE154751T1 (de) 1997-07-15
DE69030974T2 (de) 1997-12-18
EP0464106B1 (en) 1997-06-25
WO1990011065A1 (en) 1990-10-04
EP0464106A1 (en) 1992-01-08
AU5341690A (en) 1990-10-22
AU631417B2 (en) 1992-11-26
DK0464106T3 (da) 1997-07-21
HK1003322A1 (en) 1998-10-23
KR0149492B1 (ko) 1998-10-01
DE69030974D1 (de) 1997-07-31
JPH04506062A (ja) 1992-10-22
US4983395A (en) 1991-01-08
CA2053272C (en) 1998-05-19

Similar Documents

Publication Publication Date Title
ES2103271T3 (es) Dispositivo para administrar un agente activo a la piel o a mucosas.
ES2035928T3 (es) Dispositivo para administrar un agente activo a la piel o a la mucosa.
US4573996A (en) Device for the administration of an active agent to the skin or mucosa
ES2044206T3 (es) Procedimiento para la obtencion de un sistema terapeutico transdermal en forma de un emplasto con varias capas.
US6120792A (en) Medicated skin patch and method for its use
JP3023989B2 (ja) 局所包帯剤、局所包帯剤の製造法および局所包帯剤の使用
JP4388068B2 (ja) 活性剤移動バリア層を含む経皮パッチ
GB8512358D0 (en) Transdermal delivery system
SE8605320D0 (sv) Therapeutic device for the administration of medicaments
ES2072397T3 (es) Metodo y dispositivo para la administracion transdermica de dexmedetomidina.
KR950007808A (ko) 약물투여용 의료용구
PT81751B (pt) Processo para a preparacao de adesivos para aplicacao de medicamentos por via transdermica
PT93431A (pt) Processo para a preparacao de um adesivo com a forma de sistema terapeutico transdermico para a administracao de substancias activas sobre a pele com uma libertacao de substancias actvas em fases
ATE288743T1 (de) Pharmazeutische trägervorrichtung welche zur verabreichung von wirkstoffen an schleimhautoberflächen geeignet ist
ES2155931T3 (es) Forma de administracion de un agente activo de liberacion prolongada en banda.
PT93191A (pt) Sistema terapeutico para a administracao retardada e controlada transdermica ou transmucosica de substancias activas
US3366112A (en) Adhesive bandage having container of liquid medicament
US3297032A (en) Adhesive bandage having container of medicament carried by removable protector strip
KR900013993A (ko) 활성물질의 국소 또는 계통적 투여를 위한 단계적 약물 방출을 나타내는 경피 시스템 및 그 용도
BR0109893A (pt) Preparação farmacêutica de lerisetron na forma de um sistema terapêutico transdêrmico, uso da preparação, uso da substância ativa lerisetron e método para administrar a substância ativa lerisetron a um paciente
ES2058627T3 (es) Sistema terapeutico para la administracion retardada y dirigida a traves de la piel o de las mucosas de sustancias activas.
FI900315A0 (fi) Saett att framstaella ett ytligt terapeutiskt system vilket innehaoller tillvaext av elakartade celler och tillvaextfoerhindrande aktivaemne, speciellt 5-fluoruracil.
JPH06261954A (ja) 遠赤外線湿布材

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 464106

Country of ref document: ES